AzTrials
AzTrials

HIV InfectionsPhase 3NCT00353405

HIV and STD Prevention for High-Risk, Inner-City, African American Youth

A Phase 3 study testing Social Skills Training and Mass media in people with HIV Infections and Sexually Transmitted Diseases, run by University of Pennsylvania at 4 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the joint and separate effectiveness of two HIV/STD prevention programs in providing protection against acquiring STDs and maintaining safer sex behavior. Read more about this study

Who is it for?
Ages 14 to 17 yearsHealthy volunteers can take part
Conditions the study is for
HIV Infections, Sexually Transmitted Diseases
What is being tested?
Social Skills Training and Mass media
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,650 participants
Where
4 sitesUnited States
Study dates
Oct 2006to Dec 2010
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Currently resides in one of the test cities

Who cannot join

  • Presence of mental impairments

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • Emory University, Rollins School of Public Health

    Atlanta, Georgia, 30322

  • University of South Carolina, Arnold School of Public Health

    Columbia, South Carolina, 29208

  • Brown University, Rhode Island Hospital

    Providence, Rhode Island, 02903

  • Syracuse University, Department of Psychology

    Syracuse, New York, 13244

Other trials in United States

About this study

Official title: A Multilevel HIV Prevention Strategy for High-Risk Youth

This study will evaluate the joint and separate effectiveness of two HIV/STD prevention programs in providing protection against acquiring STDs and maintaining safer sex behavior.

Read the detailed description

Approximately 25% of the new HIV cases in the United States each year occur among adolescents. Although African American teens make up only 15% of the adolescent population in the U.S., they account for about two thirds of new AIDS cases among teens. An Atlanta, Georgia study involving a population composed primarily of urban African American teens demonstrated that few of the teens who tested positive for HIV were aware of the risks involved in sexual activity. Because of this population's increased risk for contracting HIV and other STDs, prevention programs that specifically target African American teens are necessary. This study will evaluate the joint and separate effectiveness of two HIV/STD prevention programs, small group training and mass media messages, in providing protection against acquiring STDs and maintaining safer sex behavior.

African American adolescents will be recruited for this single-blind, 18-month study through community-based organizations in four different cities. All participants will first complete a computer-administered survey to assess sexual attitudes, beliefs, and behaviors. They will also provide a urine sample for STD testing. Following these baseline assessments, participants will be randomly assigned to either the Focus on Youth (FOY) HIV prevention program or the Promoting Health Among Teens general health intervention. Both programs will involve eight 1-hour small group sessions that will occur over three Saturdays. Participants in the FOY program will learn safe sex and abstinence skills. Participants in the Promoting Health Among Teens intervention will receive general health information about diet, substance use, and appropriate screening for common health conditions other than STDs. All participants who test positive for an STD during the study will receive treatment. Follow-up assessments will occur at Months 6, 12, and 18 post-intervention to determine program effectiveness.

The second prevention program, mass media messages, will be administered among all participating African American teens in one of the two participating Northern cities and one of the two participating Southern cities. Cities that will receive the media intervention will be randomly selected. The other city in each pair will serve as a control city. Tailored HIV/STD prevention messages will be delivered through local mass media. Telephone interviews will be conducted over a 34-month period among 900 randomly selected teens from both media and non-media cities to assess community-wide effectiveness of the program.

Being tested
Social Skills Training, Mass media, Control
Keywords
Adolescents, Sexually Transmitted Infections, Gonorrhea, Chlamydia Infections
Medical subject headings
HIV Infections, Sexually Transmitted Diseases, Gonorrhea, Chlamydia Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social Skills TrainingBehavioural

    Social skills training includes two 8-hour sexual health skills building sessions conducted in the community.

  • Mass mediaBehavioural

    Mass media provides messages that support sexual health skills.

  • ControlBehavioural

    Control group received no social skills training and no media mass media messages.

Study groups in NCT00353405
Study groupRoleWhat they receive
1ExperimentalParticipants receiving social skills training and mass media messages
Receives: Behavioral: Social Skills Training; Behavioral: Mass media
2ExperimentalParticipants receiving social skills training and no mass media messages
Receives: Behavioral: Social Skills Training
3ExperimentalParticipants receiving mass media messages and no social skills training
Receives: Behavioral: Mass media
4ExperimentalParticipants receiving no social skills training and no mass media messages
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. STD incidence

    Measured: Measured at Months 6, 12, and 18 post-treatment

Secondary outcomes (1)
  1. Number of unprotected sexual occasions

    Measured: Measured at Months 6, 12, and 18 post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2006 (estimated)
  2. Study startOct 2006
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,650 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00353405
Sponsor's protocol ID
U01MH066809
Other IDs
U01MH066809, DAHBR 9A-ASAC
Status last verified
Jan 2012
First submitted
14 Jul 2006
Last updated
19 Jan 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Foley JD, Vanable PA, Brown LK, Carey MP, DiClemente RJ, Romer D, Valois RF. Depressive symptoms as a longitudinal predictor of sexual risk behaviors among African-American adolescents. Health Psychol. 2019 Nov;38(11):1001-1009. doi: 10.1037/hea0000780. Epub 2019 Aug 5.

    PubMed 31380687
  • Hennessy M, Romer D, Valois RF, Vanable P, Carey MP, Stanton B, Brown L, DiClemente R, Salazar LF. Safer sex media messages and adolescent sexual behavior: 3-year follow-up results from project iMPPACS. Am J Public Health. 2013 Jan;103(1):134-40. doi: 10.2105/AJPH.2012.300856. Epub 2012 Nov 15.

    PubMed 23153149

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Social Skills Training and Mass media in people with HIV Infections and Sexually Transmitted Diseases, run by University of Pennsylvania at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jan 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

STD incidence (time frame: Measured at Months 6, 12, and 18 post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00353405, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jan 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in